Gastrointestinal Disease Treatment Market is Projected to Show Slow Growth as Major Medicines such as Nexium and Crestor Continuing to Lose Patent Protection in Key Markets | GlaxoSmithKline plc, Takeda Pharmaceutical and Pfizer, Inc.

AnalystView Market Insights recently introduced in-depth study on Global Gastrointestinal Disease Treatment Market, describing about different types, route of administration, and geographies which elaborates market outlook and status to 2025.

According to this study, by the end of 2025, global gastrointestinal disease treatment market is expected to reach USD 61.06 billion, growing at the growth rate of 5.8%. This proposed study provides comprehensive analysis based on industry’s growth potential, market drivers, barriers, future opportunities, key players’ market strategies, potential pipeline therapeutics, patent analysis and detailed qualitative analysis for industry segments. Strategic analyses such as Porter’s five forces, PEST analysis, leading companies’ market share (value %), and value chain analysis will also be included which will help you to take strategic decision with respect to this market.

Gastrointestinal disorders include chronic, acute, recurrent as well as functional disorders which cover the wide range of GIT track diseases. Some of the most common GIT disorders include Crohn’s disease, GIT cancers, inflammatory bowel disease, irritable bowel syndrome, diarrhoea, dyspepsia, and others. The continuous increase in the prevalence of these diseases is expected to support the market growth to great extent. Additionally, the advent of better formulation techniques, bio-simulation software that may facilitate the drug development and discovery process and aid in faster GIT drug approval, leading to augment the market growth. Several initiatives were taken up by UNICEF and WHO aimed at providing affordable and easy access to diagnostics, treatment and preventive care also raising awareness among individuals is also expected to boost the market. However, rising number of patent expiry and lack of innovation owing to recommendations from regulatory bodies for prescription of generic and stringent regulatory approval process is expected to hinder the market.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av144/

Key Takeaways:

• The branded segment accounted for the largest share of the total market, captured more than 72.56% share in 2017. High cost coupled with patent exclusivity helped this segment to capture larger share.
• PPIs include drugs such as Prevacid, Nexium, AcipHex, Protonix, Zegerid, Prilosec, and others. Whereas, enzyme replacement therapy includes the overall market study of drugs such as Zenpep, Creon, Cholbam. Kuvan, Ultresa, Viokase, Ravicti, Cerdelga, Buphenyl, and others.
• Remicade, Tysabri, Humira, Cimzia, Entyvio, and Remsima are some of the prominent biologics for GIT disorder treatment. This segment is projected to grow with the highest growth rate over the future period owing to its high efficacy for treatment of GIT disorders.
• Oral and intravenous route of administration captured the significant share of the total market owing to the availability of safe and effective therapeutics that can be administered through oral and intravenous route.
• North America dominated the global market. In 2017, the region recorded USD 14.48 billion and is projected to dominate the market in future.
• Asia Pacific region is expected to grow with the highest CAGR over the forecast period. Growth in this region is primarily supported by the continuous rise in an incidence rate of gastrointestinal disorders, aging population, as well as the growing awareness in the emerging economies, such as China and India.
• Companies such as Abbott, Allergan, GlaxoSmithKline plc, Takeda Pharmaceutical and Pfizer, Inc., are profiled in the report

Click here to obtain more highlight on “Gastrointestinal Disease Treatment Market, By Types, By Route and Geography – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” study @
www.analystviewmarketinsights.com/report-highlight-gastrointestinal-disease-treatment-market-144/

Global Gastrointestinal Disease Treatment Market: Snapshot

Market, By Types
1. Branded
- Proton Pump Inhibitors
- Enzyme Replacement Therapies
- Amino-salicylates
- Antacids
- Anti-emetics
- Anti-diarrheal
- Biologics
- Others
2. Generics

Market, By Route of Administration
- Oral
- Intravenous
- Others

Market, by Region
- North America (U.S. and Canada)
- Europe (France and Germany)
- Asia Pacific (India and China)
- Middle East and Africa
- Latin America
- Rest of the World

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
- Abbott Laboratories
- Allergan
- GlaxoSmithKline plc
- Takeda Pharmaceutical
- Pfizer, Inc.

USP of our key vendor analysis:
- Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
- Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.